Deltex Medical Group plc / Fundamentals
Income statement
- Net revenue
€4.80M - Cost of goods sold
€1.59M - Gross profit
€3.21M - SG&A expenses
€4.62M - R&D expenses
€331.87K - EBITDA
-€2.02M - D&A
€221.25K - EBIT
-€2.35M - Interest expenses
€389.49K - EBT
-€2.76M - Tax expenses
-€92.19K - Net income
-€2.66M
Cash flow statement
- Net deferred tax
-€477.07K - Non-cash items
-€790.50K - Changes in working capital
€1.02M - Operating cash flow
-€1.83M - Capex
€749.02K - Other investing cash flow
-€840.06K - Net investing cash flow
-€878.08K - Total cash dividends paid
€0.00 - Issuance of common stock
€1.95M - Debt repayment
-€58.77K - Other financing cash flow
€2.41M - Net financing cash flow
€2.35M - Foreign exchange effects
€24.20K - Net change in cash
€483.98K - Cash at end of period
€375.66K - Free cash flow
-€1.08M
Balance sheet
- Cash and cash equivalents
€375.66K - Cash and short-term investments
€375.66K - Total receivables
€277.71K - Inventory
€752.48K - Other current assets
€250.06K - Total current assets
€1.66M - Property, plant & equipment
€194.75K - Goodwill
€0.00 - Intangible assets
€4.49M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€4.68M - Total assets
€6.34M - Accounts payable
€222.40K - Short-term debt
€993.32K - Other current liabilities
€645.31K - Total current liabilities
€1.86M - Long-term debt
€1.29M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€87.58K - Total non-current liabilities
€1.38M - Total liabilities
€3.24M - Common stock
€8.36M - Retained earnings
-€67.20M - Other equity
€20.99M - Total equity
€3.10M - Total liabilities and shareholders' equity
€6.34M
Company information
- Market capitalization
€761.46K - Employees
24 - Enterprise Value
€2.32M
Company ratios
- Gross margin
-
66.8% Better than peer group: 54.4% - EBITDA margin
-
-42.0% Much worse than peer group: -3.1% - EBIT margin
-
-49.0% Much worse than peer group: -11.9% - EBT margin
-
-57.5% Much worse than peer group: -13.6% - Net margin
-
-55.5% Much worse than peer group: -14.0% - ROE
-
-86.0% Much better than peer group: -120.9% - ROA
-
-42.0% Much worse than peer group: -7.3% - Asset turnover
-
75.7% Much worse than peer group: 190.4% - FCF margin
-
-53.7% Much worse than peer group: -12.9% - FCF yield
-338.1% - Efficiency ratio
142.0% - Net sales per employee
-
€199.93K - Net income per employee
-
-€111.01K